Assignee
LUOXIN PHARMACEUTICAL SHANGHAI CO LTD
CN·5 granted patents·2 pending applications·5 citations·filing 2017–2019
Top patents by PatentIndex Score
7 records- 0177US11034653B2Crystal form of estrogen receptor inhibitor and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Granted Jun 15, 2021·2 cites·12 claims
- 0276US10519143B2Substituted-indole-compounds as estrogen receptor down-regulatorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Dec 31, 2019·3 cites·25 claims
- 0362US12098127B2Salt form of estrogen receptor downregulator, crystalline form thereof, and preparation method thereforLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted Sep 24, 2024·0 cites·10 claims
- 0449US2020317660A1Quinazolinone Compound and Application ThereofLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2018·Application pending·0 cites
- 0547US10774081B2Indolo substituted piperidine compound as estrogen receptor down-regulatorLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Granted Sep 15, 2020·0 cites·5 claims
- 0639US11639355B2Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitorsLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2019·Granted May 2, 2023·0 cites·15 claims
- 0737US2019284192A1Nitrogenous macrocyclic compound, preparation method therefor, pharmaceutical composition and application thereofLUOXIN PHARMACEUTICAL SHANGHAI CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LUOXIN PHARMACEUTICAL SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →